Journal
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 14, Issue 8, Pages 583-589Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/15622975.2011.616533
Keywords
Brain-derived neurotrophic factor ( BDNF); serum; Val66Met; NTRK3; GWAS
Categories
Funding
- Intramural Research Program of the NIH, National Institute on Aging
Ask authors/readers for more resources
Objectives. Lower levels of serum brain derived neurotrophic factor (BDNF) is one of the best known biomarkers of depression. To identify genetic variants associated with serum BDNF, we tested the Val66Met (rs6265) functional variant and conducted a genome-wide association scan (GWAS). Methods. In a community-based sample (N = 2054; aged 19-101, M = 51, SD = 15) from Sardinia, Italy, we measured serum BDNF concentration and conducted a GWAS. Results. We estimated the heritability of serum BDNF to be 0.48 from sib-pairs. There was no association between serum BDNF and Val66Met in the SardiNIA sample and in a meta-analysis of published studies (k = 13 studies, total n = 4727, P = 0.92). Although no genome-wide significant associations were identified, some evidence of association was found in the BDNF gene (rs11030102, P = 0.001) and at two loci (rs7170215, P = 4.8 x 10 (5) and rs11073742 P = 1.2 x 10 (5)) near and within NTRK3 gene, a neurotrophic tyrosine kinase receptor. Conclusions. Our study and meta-analysis of the literature indicate that the BDNF Val66Met variant is not associated with serum BDNF, but other variants in the BDNF and NTRK3 genes might regulate the level of serum BDNF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available